|Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial|
S Sundar, PK Sinha, M Rai, DK Verma, K Nawin, S Alam, J Chakravarty, ...
The Lancet 377 (9764), 477-486, 2011
|Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis|
SK Bhattacharya, PK Sinha, S Sundar, CP Thakur, TK Jha, K Pandey, ...
The Journal of infectious diseases 196 (4), 591-598, 2007
|Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani|
B Purkait, A Kumar, N Nandi, AH Sardar, S Das, S Kumar, K Pandey, ...
Antimicrobial agents and chemotherapy 56 (2), 1031-1041, 2012
|A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India|
TK Jha, S Sundar, CP Thakur, JM Felton, AJ Sabin, J Horton
The American journal of tropical medicine and hygiene 73 (6), 1005-1011, 2005
|Diagnosis & management of leishmania/HIV co-infection|
PK Sinha, K Pandey, SK Bhattacharya
Indian Journal of Medical Research 121 (4), 407, 2005
|Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection|
J Mookerjee Basu, A Mookerjee, R Banerjee, M Saha, S Singh, K Naskar, ...
Antimicrobial agents and chemotherapy 52 (3), 1080-1093, 2008
|Assessing latrine use in rural India: a cross-sectional study comparing reported use and passive latrine use monitors|
A Sinha, CL Nagel, E Thomas, WP Schmidt, B Torondel, S Boisson, ...
The American journal of tropical medicine and hygiene 95 (3), 720, 2016
|Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar, India|
RK Topno, VNR Das, A Ranjan, K Pandey, D Singh, N Kumar, ...
The American journal of tropical medicine and hygiene 83 (3), 502, 2010
|Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India|
VP Singh, A Ranjan, RK Topno, RB Verma, NA Siddique, VN Ravidas, ...
The American journal of tropical medicine and hygiene 82 (1), 9, 2010
|Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India|
PK Sinha, J van Griensven, K Pandey, N Kumar, N Verma, R Mahajan, ...
Clinical Infectious Diseases 53 (7), e91-e98, 2011
|Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus|
R Kumar, M Nayak, GC Sahoo, K Pandey, MC Sarkar, Y Ansari, VNR Das, ...
Journal of Infection and Chemotherapy 25 (5), 325-329, 2019
|SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021|
MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ...
International Journal of Infectious Diseases 108, 145-155, 2021
|In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani|
V Lakshmi, K Pandey, A Kapil, N Singh, M Samant, A Dube
Phytomedicine 14 (1), 36-42, 2007
|Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani|
R Kumar, GC Sahoo, K Pandey, VNR Das, P Das
Drug delivery 22 (3), 383-388, 2015
|Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar|
VNR Das, A Ranjan, S Bimal, NA Siddique, K Pandey, N Kumar, N Verma, ...
National Medical Journal of India 18 (3), 130, 2005
|Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)|
S Burza, R Mahajan, PK Sinha, J van Griensven, K Pandey, MA Lima, ...
PLoS neglected tropical diseases 8 (8), e3053, 2014
|Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes|
VNR Das, NA Siddiqui, RB Verma, RK Topno, D Singh, S Das, A Ranjan, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (11 …, 2011
|Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani|
P Bhattacharya, S Ghosh, SA Ejazi, M Rahaman, K Pandey, VN Ravi Das, ...
PLoS neglected tropical diseases 10 (2), e0004422, 2016
|Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India|
R Mahajan, P Das, P Isaakidis, T Sunyoto, KD Sagili, MA Lima, G Mitra, ...
Clinical Infectious Diseases 61 (8), 1255-1262, 2015
|Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T …|
MR Dikhit, A Kumar, S Das, B Dehury, AK Rout, F Jamal, GC Sahoo, ...
Frontiers in immunology 8, 1763, 2017